Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Donahue

BioReference Laboratories has hired Joseph Donahue to serve as senior vice president of the company's new Commercial Collaborations and Innovations group, which will focus on providing solutions that support pharmaceutical innovation, development, and go-to-market activities.

Previously, Donahue was senior vice president and global head of Thomson Reuters' Business Development and Innovation unit, where he led efforts to build a life sciences business that provided competitive intelligence, big data information solutions, intellectual property, and consulting services to industry and academia. He's spent much of his 30-year career working on providing life sciences organizations with informatics solutions that help speed up their research and development efforts.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.